Archive for the ‘Arthritis’ Category
Wednesday, December 12th, 2007
The Arthritis Foundation, the leading health organization addressing the needs of 46 million Americans living with arthritis, announced that Amgen and Wyeth Pharmaceuticals, co-marketers of Enbrel® (etanercept), will be the national presenting sponsor of the 2008 Arthritis Walk®. "The Arthritis Foundation hosts hundreds of Arthritis Walk events nationwide to raise ...
Posted in Arthritis | No Comments »
Monday, December 10th, 2007
A study published in the December issue of Arthritis Care & Research estimates that 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition. The study, conducted by the Centers for Disease Control and Prevention (CDC), provides for ...
Posted in Arthritis | No Comments »
Thursday, December 6th, 2007
Concerns over the cardiovascular safety of non-steroidal anti-inflammatory drugs (NSAIDs) led to the publication of several sets of fresh guidelines on the treatment of knee osteoarthritis. But a review of these guidelines, published in the online open access journal, Arthritis Research & Therapy, found many differences in treatments addressed and ...
Posted in Arthritis | No Comments »
Monday, December 3rd, 2007
For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human ...
Posted in Arthritis | No Comments »
Thursday, November 22nd, 2007
Roche announced the submission of a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for ACTEMRATM (tocilizumab) to reduce the signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA). ...
Posted in Arthritis | No Comments »
Wednesday, November 21st, 2007
Meyer Pharmaceuticals LLC announced that it has obtained a license for a new drug technology for the treatment of inflammatory conditions such as arthritis and skin disease. The drug is a patented oligonucleotide (a small segment of DNA) that specifically blocks NF-kB, a transcription factor that activates pro-inflammatory genes. The ...
Posted in Arthritis | No Comments »
Sunday, November 18th, 2007
Researchers at Cincinnati Children's have issued the first study showing that a protein normally involved in blood clotting (fibrin), also plays an important role in the inflammatory response and development of rheumatoid arthritis. Inflammatory joint disease appears to be driven by the engagement of inflammatory cells with fibrin matrices through ...
Posted in Arthritis | No Comments »
Monday, November 12th, 2007
Two studies released reaffirmed TNF inhibitors, biologic agents often used to treat adults with rheumatoid arthritis, are safe and effective treatments for children with juvenile arthritis (JA). The two drugs, adalimumab and etanercept, were studied separately. One study focused solely on the effectiveness of adalimumab in children and the other ...
Posted in Arthritis | No Comments »
Saturday, November 10th, 2007
The MabThera Virtual Clinic - an exciting web-based resource - is a new initiative that provides physicians with key insights into the use of MabThera (rituximab), the first and only selective B cell therapy for the treatment of rheumatoid arthritis (RA). Using anonymised real-life cases of RA patients from around ...
Posted in Arthritis | No Comments »
Wednesday, November 7th, 2007
Mice that don't produce lubricin, a thin film of protein found in the cartilage of joints, showed early wear and higher friction in their joints, a new study led by Brown University researchers shows.This link between increased friction and early wear in joints is a first; no other team of ...
Posted in Arthritis | No Comments »
Wednesday, November 7th, 2007
Advanced Bio-Surfaces, Inc., (ABS) an orthopedic implant developer and manufacturer, announced the OrthoGlide Medial Knee Implant has been implanted in more than 300 patients in the USA. The OrthoGlide implant is a minimally invasive device intended to relieve pain caused by moderate osteoarthritis of the knee. "The interest ...
Posted in Arthritis | No Comments »
Sunday, October 28th, 2007
In a snub to thousands of people with rheumatoid arthritis, the National Institute of Health and Clinical Excellence (NICE) has published final guidance stating that the drug abatacept (Orencia) is not cost effective for the NHS and should be refused. The drug for severe rheumatoid arthritis (RA) was only ...
Posted in Arthritis | No Comments »
Thursday, October 25th, 2007
Scientists at Case Western Reserve University's School of Medicine have published in the Journal of Inflammation a remarkable discovery with a natural product derived from the Amazon rainforest. The discovery's unique actions suggest a broad set of applications in various joint, skin and gastrointestinal diseases, including osteoarthritis and irritable bowel ...
Posted in Arthritis | No Comments »
Thursday, October 25th, 2007
The National Institute for Health and Clinical Excellence (NICE) recommended Humira (adalimumab) as an option for the treatment of adults with rheumatoid arthritis (RA). It is the second positive opinion for adalimumab for rheumatological conditions in as many months, having been recommended by NICE for the treatment of psoriatic ...
Posted in Arthritis | No Comments »
Wednesday, October 24th, 2007
Metagenics, Inc., a leading developer and manufacturer of science-based medical foods and nutraceuticals sold through healthcare practitioners, announced that it has been awarded three new patents for discoveries relating to Luduxin™ and Tetrase™, two all-natural selective kinase response modifier (SKRM) formulations with powerful anti-inflammatory properties. U.S. Patent no. 7,270,835 ...
Posted in Arthritis | No Comments »
